BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18795697)

  • 1. Indocyanine green disappearance rate is the most useful marker for liver resection.
    Scheingraber S; Richter S; Igna D; Flesch S; Kopp B; Schilling MK
    Hepatogastroenterology; 2008; 55(85):1394-9. PubMed ID: 18795697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy.
    Scheingraber S; Richter S; Igna D; Girndt M; Flesch S; Kleinschmidt S; Schilling MK
    Clin Transplant; 2007; 21(6):689-95. PubMed ID: 17988260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure.
    de Liguori Carino N; O'Reilly DA; Dajani K; Ghaneh P; Poston GJ; Wu AV
    Eur J Surg Oncol; 2009 Sep; 35(9):957-62. PubMed ID: 19250796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients.
    Reekers M; Simon MJ; Boer F; Mooren RA; van Kleef JW; Dahan A; Vuyk J
    Anesth Analg; 2010 Feb; 110(2):466-72. PubMed ID: 20081133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
    Parker BM; Cywinski JB; Alster JM; Irefin SA; Popovich M; Beven M; Fung JJ
    Liver Transpl; 2008 Jan; 14(1):46-52. PubMed ID: 18161838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
    Levesque E; Saliba F; Benhamida S; Ichaï P; Azoulay D; Adam R; Castaing D; Samuel D
    Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT; Memiş D; Kargi M; Sut N
    J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
    Lao XM; Zhang YQ; Lin XJ; Guo RP; Chen MS; Yuan YF; Li JQ; Li GH
    Ai Zheng; 2005 Mar; 24(3):337-40. PubMed ID: 15757537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria.
    Kobayashi Y; Kiya Y; Nishioka Y; Hashimoto M; Shindoh J
    HPB (Oxford); 2020 Feb; 22(2):258-264. PubMed ID: 31326264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À; Mas A; Fernández J; García-Valdecasas JC
    Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICG pulse spectrophotometry for perioperative liver function in hepatectomy.
    Okochi O; Kaneko T; Sugimoto H; Inoue S; Takeda S; Nakao A
    J Surg Res; 2002 Mar; 103(1):109-13. PubMed ID: 11855925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study.
    Memiş D; Kargi M; Sut N
    J Crit Care; 2009 Dec; 24(4):603-8. PubMed ID: 19931154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients.
    Mizuguchi T; Kawamoto M; Meguro M; Son S; Nakamura Y; Harada K; Shibata T; Ota S; Hirata K
    Hepatogastroenterology; 2012; 59(114):551-7. PubMed ID: 22353523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyaluronic acid measurement to assess the hepatic functional reserve.
    Suehiro T; Matsumata T; Shikada Y; Shimada M; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2004; 51(60):1776-9. PubMed ID: 15532824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study.
    Steinvall I; Fredrikson M; Bak Z; Sjoberg F
    Burns; 2012 Mar; 38(2):214-24. PubMed ID: 22040928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry.
    Sugimoto H; Okochi O; Hirota M; Kanazumi N; Nomoto S; Inoue S; Takeda S; Nakao A
    J Hepatobiliary Pancreat Surg; 2006; 13(6):543-8. PubMed ID: 17139429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements.
    Thomas MN; Weninger E; Angele M; Bösch F; Pratschke S; Andrassy J; Rentsch M; Stangl M; Hartwig W; Werner J; Guba M
    HPB (Oxford); 2015 Jun; 17(6):471-6. PubMed ID: 25581073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
    Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
    Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.